Published in Bull Eur Physiopathol Respir on February 17, 1986
Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A (1994) 2.28
Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol (1992) 2.24
End points in pulmonary arterial hypertension: the way forward. Eur Respir J (2004) 2.21
Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation (1982) 1.92
A redox-based O2 sensor in rat pulmonary vasculature. Circ Res (1993) 1.83
Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res (1976) 1.76
Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ Res (1996) 1.74
Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel. J Clin Invest (1996) 1.72
Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals. Am Rev Respir Dis (1982) 1.70
Hypoxaemia and aortic chemoreceptor function in foetal lambs. J Physiol (1969) 1.68
O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc Natl Acad Sci U S A (1999) 1.67
Congenital pulmonary lymphangiectasis. Am J Dis Child (1970) 1.64
Hypoxic ventilatory drive in normal man. J Clin Invest (1970) 1.62
Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol (1985) (1988) 1.60
Nonimmunological production of leukotrienes induced by platelet-activating factor. Science (1982) 1.58
Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol (1985) (1987) 1.56
Cyanide stimulation of the systemic arterial chemoreceptors in foetal lambs. J Physiol (1969) 1.55
A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD. Chest (1996) 1.52
Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun (1989) 1.46
Internal carotid arterial flow velocity during exercise in Tibetan and Han residents of Lhasa (3,658 m). J Appl Physiol (1985) (1992) 1.43
High-altitude pulmonary edema in the children and young adults of Leadville, Colorado. N Engl J Med (1977) 1.43
Histamine H1- and H2-receptors in pulmonary and systemic vasculature of the dog. Am J Physiol (1975) 1.40
Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J Appl Physiol (1985) (1987) 1.40
The red cell mass--arterial oxygen relationship in normal man. Application to patients with chronic obstructive airway disease. J Clin Invest (1968) 1.39
Circulatory adaptation to high altitude. Annu Rev Med (1968) 1.32
The genetic factor influencing pulmonary hypertension in cattle at high altitude. Cardiovasc Res (1974) 1.30
Chronic obstructive bronchopulmonary disease. II. Oxygen transport in two clinical types. Am J Med (1968) 1.28
Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation (1971) 1.27
Operation Everest II: pulmonary gas exchange during a simulated ascent of Mt. Everest. J Appl Physiol (1985) (1987) 1.24
Impaired oxygenation during sleep in excessive polycythemia of high altitude: improvement with respiratory stimulation. Sleep (1978) 1.23
The case for treatment of selected patients with primary pulmonary hypertension. Am Rev Respir Dis (1986) 1.21
Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol (1985) (2001) 1.19
Pre-excitation as a cause of appearance and increased intensity of systolic murmurs. Circulation (1966) 1.17
Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. J Clin Invest (1972) 1.15
Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol (1978) 1.15
Acclimatization to 4,300-m altitude decreases reliance on fat as a substrate. J Appl Physiol (1985) (1996) 1.14
Acquired attenuation of chemoreceptor function in chronically hypoxic man at high altitude. J Clin Invest (1971) 1.14
Redox status in the control of pulmonary vascular tone. Herz (1986) 1.12
Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med (1983) 1.11
Hypoxic ventilatory responsiveness in Tibetan compared with Han residents of 3,658 m. J Appl Physiol (1985) (1993) 1.11
Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Natl Acad Sci U S A (1996) 1.11
Subnormal cardiac output at rest and during exercise in residents at 3,100 m altitude. J Appl Physiol (1967) 1.11
Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology (1995) 1.11
Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physiol (1985) (1994) 1.10
Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxide. Biochem Biophys Res Commun (1989) 1.10
"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris. J Am Coll Cardiol (1984) 1.09
Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude. Am J Physiol (1975) 1.09
Lung mast cell hyperplasia and pulmonary histamine-forming capacity in hypoxic rats. Am J Physiol (1974) 1.09
Potassium channels regulate tone in rat pulmonary veins. Am J Physiol Lung Cell Mol Physiol (2001) 1.09
Purulent pericarditis in children: an analysis of 28 cases. Thorax (1977) 1.09
Increased dependence on blood glucose after acclimatization to 4,300 m. J Appl Physiol (1985) (1991) 1.09
Ventilatory control in the athlete. J Appl Physiol (1971) 1.08
Systemic hypertension at 4,300 m is related to sympathoadrenal activity. J Appl Physiol (1985) (1994) 1.08
Measurement of cardiac output by electrical impedance at rest and during exercise. J Appl Physiol (1976) 1.08
Muscle accounts for glucose disposal but not blood lactate appearance during exercise after acclimatization to 4,300 m. J Appl Physiol (1985) (1992) 1.08
Reversal of high altitude pulmonary hypertension. Am J Cardiol (1966) 1.08
Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol (1987) 1.07
Physiological effects of high altitude on the pulmonary circulation. Int Rev Physiol (1979) 1.07
Functional capacities of lungs and thorax in beagles after prolonged residence at 3,100 m. J Appl Physiol (1985) (1985) 1.07
Sympathetic and parasympathetic indicators of heart rate control at altitude studied by spectral analysis. J Appl Physiol (1985) (1994) 1.06
Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol (1985) 1.06
Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation. Adv Exp Med Biol (2000) 1.06
Fluid retention and relative hypoventilation in acute mountain sickness. Respiration (1982) 1.06
Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J Lab Clin Med (1976) 1.06
Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol Lung Cell Mol Physiol (2002) 1.05
Decreased reliance on lactate during exercise after acclimatization to 4,300 m. J Appl Physiol (1985) (1991) 1.05
Arterial catecholamine responses during exercise with acute and chronic high-altitude exposure. Am J Physiol (1991) 1.05
Role of red cell 2,3-diphosphoglycerate in the adaptation of man to altitude. J Lab Clin Med (1969) 1.05
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol (1985) (1993) 1.05
Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol (1992) 1.04
Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology (1996) 1.04
The mitogenic effects of the B beta chain of fibrinogen are mediated through cell surface calreticulin. J Biol Chem (1995) 1.03
Operation Everest II: man at extreme altitude. J Appl Physiol (1985) (1987) 1.03
Greater maximal O2 uptakes and vital capacities in Tibetan than Han residents of Lhasa. Respir Physiol (1990) 1.02
Simultaneous measurement of O2 radicals and pulmonary vascular reactivity in rat lung. J Appl Physiol (1985) (1989) 1.02
Effects of alpha adrenergic blockade and tissue catecholamine depletion on pulmonary vascular response to hypoxia. J Clin Invest (1968) 1.02
Altitude and beta-blockade augment glucose utilization during submaximal exercise. J Appl Physiol (1985) (1996) 1.02
Opposing effects of oxidants and antioxidants on K+ channel activity and tone in rat vascular tissue. Exp Physiol (1995) 1.02
Successful replacement of a thrombosed mitral ball-valve prosthesis. JAMA (1965) 1.02
Lungs from chronically hypoxic rats have decreased pressor response to acute hypoxia. Am J Physiol (1978) 1.01
Reduction of stroke volume during exercise in man following ascent to 3,100 m altitude. J Appl Physiol (1967) 1.01
The non specificity of specific nitric oxide synthase inhibitors. Biochem Biophys Res Commun (1992) 1.00
Inflammatory processes may predispose children to high-altitude pulmonary edema. J Pediatr (1997) 1.00
Pulmonary circulation in animals and man at high altitude. Ann N Y Acad Sci (1965) 0.99
Infant birth weight is related to maternal arterial oxygenation at high altitude. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.99
Does normoxic pulmonary vasodilatation rather than hypoxic vasoconstriction account for the pulmonary pressor response to hypoxia? Lancet (1978) 0.99
Poor relationship between arterial [lactate] and leg net release during exercise at 4,300 m altitude. Am J Physiol (1998) 0.98